By: PTI | Original Delhi |
July 29, 2021 4: 29: 02 pm
As a phase of the OFS, Vimla Windlass will offload 11.36 lakh equity shares, and investor Tano India Interior most Fairness Fund II will promote 40,06,067 equity shares. (E book image: Pixabay)
Windlas Biotech, manufacturer of pharmaceutical formulations, on Thursday mentioned it has mounted a heed band of Rs 448-460 a share for its preliminary share-sale.
The three-day preliminary public provide (IPO) will launch on August 4 and perform on August 6, the firm presented in a digital press conference.
The IPO contains current issuance of equity shares price Rs 165 crore and and a proposal for sale of up to 5,142,067 equity shares.
As a phase of the OFS, Vimla Windlass will offload 11.36 lakh equity shares, and investor Tano India Interior most Fairness Fund II will promote 40,06,067 equity shares.
At the upper waste of the price band, the preliminary share-sale will obtain Rs 401.53 crore.
The proceeds from the IPO will be utilised for buying of instruments required for capability growth of the facility at Dehradun Plant -IV and addition of injectables dosage capability at the facility at Dehradun Plant-II.
This may maybe well per chance well even be historical for funding incremental working capital requirements, compensation/ prepayment of definite of borrowings and standard corporate capabilities.
Half of of the venture dimension has been reserved for certified institutional patrons (QIBs), 35 per cent for retail patrons and the perfect 15 per cent for non institutional patrons.
Guide running lead managers to the venture are SBI Capital Markets Ltd, DAM Capital ad IIFL Securities.
📣 The Indian Recount is now on Telegram. Click on right here to join our channel (@indianexpress) and cease awake to this point with basically the most modern headlines
